Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of life.
Panse J, Sicre de Fontbrune F, Burmester P, Piggin M, Matos JE, Costantino H, Wilson K, Hakimi Z, Nazir J, Desgraz R, Fishman J, Persson E, Kulasekararaj A. Panse J, et al. Among authors: persson e. Eur J Haematol. 2022 Oct;109(4):351-363. doi: 10.1111/ejh.13816. Epub 2022 Jul 7. Eur J Haematol. 2022. PMID: 35746830 Free PMC article.
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective.
Sicre de Fontbrune F, Burmester P, Piggin M, Matos JE, Costantino H, Wilson K, Hakimi Z, Nazir J, Desgraz R, Fishman J, Persson E, Panse J. Sicre de Fontbrune F, et al. Among authors: persson e. Hematology. 2022 Dec;27(1):1140-1151. doi: 10.1080/16078454.2022.2127630. Hematology. 2022. PMID: 36165770 Free article.
Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors.
Panse J, Daguindau N, Okuyama S, Peffault de Latour R, Schafhausen P, Straetmans N, Al-Adhami M, Persson E, Wong RSM. Panse J, et al. Among authors: persson e. PLoS One. 2024 Jul 29;19(7):e0306407. doi: 10.1371/journal.pone.0306407. eCollection 2024. PLoS One. 2024. PMID: 39079163 Free PMC article. Clinical Trial.
New developments for the Quest for Orthologs benchmark service.
Altenhoff A, Nevers Y, Tran V, Jyothi D, Martin M, Cosentino S, Majidian S, Marcet-Houben M, Fuentes-Palacios D, Persson E, Walsh T, Lecompte O, Gabaldón T, Kelly S, Hu Y, Iwasaki W, Capella-Gutierrez S, Dessimoz C, Thomas PD, Ebersberger I, Sonnhammer E. Altenhoff A, et al. Among authors: persson e. NAR Genom Bioinform. 2024 Dec 11;6(4):lqae167. doi: 10.1093/nargab/lqae167. eCollection 2024 Dec. NAR Genom Bioinform. 2024. PMID: 39664814 Free PMC article.
Effect of Oral Screen Training After Stroke-A Randomised Controlled Trial.
Dalum J, Skott P, Åkesson E, Persson E, Karlsson Å, Häbel H, Seiger Å, McAllister A, Johansson K, Sandborgh-Englund G. Dalum J, et al. Among authors: persson e. Gerodontology. 2024 Dec 5. doi: 10.1111/ger.12803. Online ahead of print. Gerodontology. 2024. PMID: 39636679
Quest for Orthologs in the Era of Biodiversity Genomics.
Langschied F, Bordin N, Cosentino S, Fuentes-Palacios D, Glover N, Hiller M, Hu Y, Huerta-Cepas J, Coelho LP, Iwasaki W, Majidian S, Manzano-Morales S, Persson E, Richards TA, Gabaldón T, Sonnhammer E, Thomas PD, Dessimoz C, Ebersberger I. Langschied F, et al. Among authors: persson e. Genome Biol Evol. 2024 Oct 9;16(10):evae224. doi: 10.1093/gbe/evae224. Genome Biol Evol. 2024. PMID: 39404012 Free PMC article. Review.
543 results